These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22609636)

  • 1. Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women.
    Makey KL; Patterson SG; Robinson J; Loftin M; Waddell DE; Miele L; Chinchar E; Huang M; Smith AD; Weber M; Gu JW
    Eur J Cancer Prev; 2013 Jan; 22(1):83-9. PubMed ID: 22609636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers.
    Bailey AP; Shparago M; Gu JW
    Med Sci Monit; 2006 Feb; 12(2):CR45-50. PubMed ID: 16449946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy.
    Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
    PLoS One; 2014; 9(7):e101779. PubMed ID: 25007257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle.
    Zolton JR; Sjaarda LA; Mumford SL; DeVilbiss EA; Kim K; Flannagan KS; Radoc JG; Perkins NJ; Silver RM; Wactawski-Wende J; Hill MJ; DeCherney AH; Schisterman EF
    Obstet Gynecol; 2021 Jan; 137(1):82-90. PubMed ID: 33278289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM; Blann AD; Lip GY
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia.
    Wieczór R; Wieczór AM; Gadomska G; Stankowska K; Fabisiak J; Suppan K; Pulkowski G; Budzyński J; Rość D
    J Zhejiang Univ Sci B; 2016 Nov.; 17(11):842-849. PubMed ID: 27819131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.
    Schommer K; Wiesegart N; Dehnert C; Mairbäurl H; Bärtsch P
    High Alt Med Biol; 2011; 12(4):323-7. PubMed ID: 22206557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.
    Yang WC; Chen CY; Chou HC; Hsieh WS; Tsao PN
    Pediatr Neonatol; 2015 Dec; 56(6):382-5. PubMed ID: 25997993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise increases endostatin in circulation of healthy volunteers.
    Gu JW; Gadonski G; Wang J; Makey I; Adair TH
    BMC Physiol; 2004 Jan; 4():2. PubMed ID: 14728720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study.
    Voller SB; Chock S; Ernst LM; Su E; Liu X; Farrow KN; Mestan KK
    Early Hum Dev; 2014 Apr; 90(4):195-200. PubMed ID: 24480606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy.
    Straughen JK; Misra DP; Kumar P; Misra VK
    Reprod Sci; 2013 Mar; 20(3):269-75. PubMed ID: 22872542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of angiogenic factors by regular and acute exercise during pregnancy.
    Weissgerber TL; Davies GA; Roberts JM
    J Appl Physiol (1985); 2010 May; 108(5):1217-23. PubMed ID: 20224004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
    Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
    Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock.
    Whitney JE; Silverman M; Norton JS; Bachur RG; Melendez E
    Pediatr Emerg Care; 2020 Dec; 36(12):e715-e719. PubMed ID: 30335688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
    Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of free vascular endothelial growth factor and its soluble receptor, sFlt-1 in the maternal and fetal circulations of normal term pregnancies at high and low altitudes.
    Ali KZ; Burton GJ; Al-Binali AM; Eskandar MA; El-Mekki AA; Moosa RA; Abd-Alla SA; Salih AG; Sideeg AM; Mahfouz AA
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2066-70. PubMed ID: 22385323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.